Limitless starting materials for large-scale manufacture of MSCs – what does the future hold?
Free-to-access Pharmaceutical Bioprocessing editorial on large-scale manufacture of mesenchymal stem cells, written by Kilian Kelly (Cynata Therapeutics, VIC, Australia)
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.